This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lo, Y.-R. J. Articles by Farley, T. M. M. Search for Related Content Social Bookmarking                         What's this?

Trends in Prevention of Mother-to-Child Transmission of HIV-1

office of WHO Representative to Thailand, c/o Ministry of Public Health, Permanent Secretary Building (3/4 Floor), Tiwanond Road, Nonthaburi 11000, Thailand E-mail: yingrulo{at}whothai.moph.go.th

Timothy M. M. Farley

Reproductive Health and Research, Avenue Appia 20, 1211 Geneva 27, Switzerland E-mail: farleyt{at}who.ch.

Mother-to-child transmission (MTCT) of HIV is the predominant mode of HIV transmission in children worldwide. It is estimated that around 1.3 million children are living with HIV and that approximately 1,600 children are infected with HIV each day. Numerous clinical trials using antiretroviral drugs to reduce MTCT of HIV-1 have shown that perinatal transmission can be reduced effectively. Based on the PACTG 076 study administering a long antenatal zidovudine regimen, a signific ant reduction in vertical HIV-1 transmission has been achieved in the developed world. Trials conducted in developing countries have shown that perinatal transmission can be reduced effectively even using shorter and less costly antiretroviral regimens. Prevention of MTCT interventions have been implemented on a large scale in a number of developing countries.

Journal of Health Management, Vol. 2, No. 2, 201-218 (2000)
DOI: 10.1177/097206340000200206


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?